Researchers have developed a novel method using CRISPR to study transcription factors affecting blood cell development. The ...

The undisclosed target is a central regulator of inflammation that is distinct from the previously disclosed STAT6 program Nurix DEL-AI drug discovery engine generated a drug discovery program to this ...

Sanofi has returned to Nurix Therapeutics for another autoimmune candidate, paying $15 million and committing up to $465 ...

A team of researchers at Karolinska Institutet has developed a novel tool for genetic research. The study, published in ...

Domain structure and transcriptional regulation of ELF4. (A) ELF4 includes six functional domains: an acidic domain, an AML1 interaction domain, a conserved ETS domain, a serine/threonine-rich ...

What's been going on in the life sciences world? Check out Week in Brief for an overview of the biggest news from the last ...

Nurix Therapeutics NRIX shares rose 8.7% on Wednesday after the company announced that Sanofi SNY has in-licensed exclusive ...

A research team led by Dr. Li Yunhai from the Institute of Genetics and Developmental Biology of the Chinese Academy of ...

A recent study has shed light on the transcriptional regulatory mechanisms of Penicillium expansum, the fungal culprit behind ...